Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.61 |
| ▸ | GABRP | O00591 | 5/20 | 0.51 |
| ▸ | GABRD | O14764 | 5/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.51 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 5/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.51 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.51 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.51 |
| ▸ | GABRA4 | P48169 | 5/20 | 0.51 |
| ▸ | GABRE | P78334 | 5/20 | 0.51 |
| ▸ | GABRA6 | Q16445 | 5/20 | 0.51 |
| ▸ | GABRG1 | Q8N1C3 | 5/20 | 0.51 |
| ▸ | GABRG3 | Q99928 | 5/20 | 0.51 |
| ▸ | GABRQ | Q9UN88 | 5/20 | 0.51 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbazole SCHEMBL27757289 | 0.77 | ALDH1A1 (0.67) | KIF11GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL2775335 | 0.76 | KIF11 (1.00) | KIF11AHRALDH1A1KDM4EMAPT | |
| SCHEMBL29823607 | 0.76 | KIF11 (1.00) | KIF11AHRALDH1A1KDM4EMAPT | |
| SCHEMBL8125643 | 0.76 | KIF11 (0.58) | KIF11GABRPGABRDGABRA1GABRB1 | |
| Carbazole SCHEMBL27643881 | 0.75 | ALDH1A1 (0.64) | KIF11GABRPGABRDGABRA1GABRB1 | |
| Tetradecane SCHEMBL9931701 | 0.75 | ALDH1A1 (0.64) | KIF11GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL4062550 | 0.74 | GABRP (0.61) | KIF11GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL31522707 | 0.74 | GABRP (0.61) | KIF11GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL31522704 | 0.74 | GABRP (0.61) | KIF11GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL8124645 | 0.73 | KIF11 (0.64) | KIF11GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | claimed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| JP-2011157353-A | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LAB CO LTD | 2011-08-18 | — | — | JP | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | CYP1A1, AHR, CYP2C9 | KIF11 3694/4885GABRP 4834/4885GABRD 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.